What CPAs Need to Know About Timing, Method Changes, and Missed Opportunities

Introduction

Recent legislative changes have reshaped how several long-standing tax incentives operate in practice. For CPAs, the result has been a mix of opportunity and confusion—particularly at the intersection of the Research & Development (R&D) tax credit, mandatory capitalization under Section 174, and accelerated depreciation strategies such as cost segregation.

Many taxpayers experienced significant cash-flow disruptions when Section 174 capitalization became mandatory. Subsequent relief provisions under the One Big Beautiful Bill Act (OBBBA) reopened planning options, but not always in intuitive ways. At the same time, changes to bonus depreciation and related elections have made timing decisions more critical than ever, especially for closely held and real estate-heavy businesses.

This article is intended to help CPAs step back from the noise and view these provisions as part of a coordinated planning framework. Rather than treating R&D credits, Section 174, and depreciation as siloed topics, the discussion focuses on how they interact, where misconceptions commonly arise, and how practitioners can quickly identify situations that merit deeper technical review.

The content is drawn from a live CPE presentation and has been reorganized to highlight practical takeaways, planning considerations, and decision points relevant to advisors working with growth-oriented, engineering-driven, and real-estate-intensive clients.

Editor’s Note: About This Article

This article is based on a live Continuing Professional Education (CPE) presentation and has been AI-assisted for readability, clarity, and organization. The intent of the original discussion has not been altered; rather, the content has been refined to translate a spoken, conversational format into a more digestible written narrative. The following content has also not been reviewed for technical accuracy, so assume caution and possible AI misinterpretation of technical topics in reading this article.

The session focused on current and emerging planning considerations surrounding the Research & Development (R&D) tax credit, Section 174 capitalization rules, and cost segregation strategies, particularly in light of recent legislative changes under the One Big Beautiful Bill Act (OBBBA). The goal of this article is to help CPAs and tax advisors more easily identify planning opportunities, understand where confusion commonly arises, and spot client situations that warrant a deeper technical review.

Why This Session Matters to CPAs Right Now

Few areas of the tax code have created as much practical confusion—and as many missed opportunities—as the intersection of the R&D tax credit, Section 174 capitalization, and accelerated depreciation strategies. Over the past several years, many CPAs have watched otherwise solid planning tools become muddied by legislative changes, delayed guidance, and inconsistent messaging across the profession.

At the same time, the stakes have never been higher. Clients are facing increased cash-flow pressure, tighter financing environments, and heightened scrutiny around tax positions. Against that backdrop, properly applied credits and timing strategies can generate six- and seven-figure cash-flow benefits, while missteps can lead to lost deductions, inefficient elections, or unnecessary compliance risk.

This session was designed with a practical objective: to help CPAs quickly recognize when a client may be leaving material tax benefits on the table—and to distinguish between situations that merit a deeper technical dive and those that do not. Rather than treating R&D credits, Section 174, and cost segregation as isolated topics, the discussion emphasized how these rules now interact, how recent legislative relief changes the analysis, and why older assumptions may no longer hold.

In short, this is not about turning every client into a tax credit project. It is about giving practitioners a clearer framework for asking the right questions, avoiding outdated conclusions, and navigating a planning landscape that has quietly—but materially—shifted.

R&D Credit in Plain English (and Why “Credit” ≠ “Deduction”)

At its core, the Research & Development (R&D) tax credit is one of the most misunderstood tools in the Internal Revenue Code—not because it is overly complex, but because it is often framed incorrectly.

The first and most important distinction is this: a tax credit is not a deduction.

A deduction reduces taxable income. A credit reduces tax liability dollar for dollar. That distinction alone materially changes the conversation with clients. A $100,000 deduction might save $21,000 in federal tax for a C corporation. A $100,000 credit saves $100,000 in tax.

Yet many taxpayers—and more than a few advisors—still mentally bucket the R&D credit alongside “aggressive deductions” or niche incentives that only apply to laboratories, tech startups, or companies in Silicon Valley. In reality, the credit was designed to reward businesses that invest in improving products, processes, software, or systems as part of their normal operations. Innovation does not need to be revolutionary. It simply needs to involve uncertainty and technical problem-solving.

From a practical standpoint, the R&D credit is also one of the few incentives that can generate retroactive value. Companies that qualify today often qualified in prior years but never claimed the credit. That creates a lookback opportunity—sometimes spanning multiple tax years—where previously paid taxes can be recovered through amended returns or accounting method adjustments, depending on the facts.

Another key point that is often missed: the credit is not limited to profitable companies. Certain taxpayers—particularly younger or growing businesses—may be able to apply the credit against payroll taxes rather than income tax, making the R&D credit a cash-flow tool, not just a tax planning concept.

The takeaway for CPAs is simple but critical. When evaluating whether the R&D credit is worth exploring, the threshold question is not “Is this client doing cutting-edge research?” It is whether the client is paying people to solve technical problems, improve how things are built or delivered, or work through uncertainty using engineering, computer science, or similar disciplines. If the answer is yes, the credit may be far more relevant—and valuable—than commonly assumed.

Common Reasons Taxpayers Think They Don’t Qualify (and Why That’s Often Wrong)

In practice, most missed R&D credits are not the result of ineligibility—they stem from assumptions. Over time, a set of recurring objections has developed around the credit, many of which sound reasonable on the surface but do not hold up under closer review of the statute, regulations, and case law.

One of the most common misconceptions is that a company must be “doing something new to the world” in order to qualify. In reality, the standard is far lower. The R&D credit is based on whether an activity is new or improved to the taxpayer, not whether it is groundbreaking in an absolute sense. Improving an internal process, refining an existing product, or developing custom software for internal use can all qualify, even if similar solutions already exist elsewhere.

Another frequent concern is the absence of formal time tracking. Many taxpayers assume that if they did not track employee hours by project, the credit is automatically off the table. While contemporaneous documentation is always preferable, the law does not require perfect time studies. Reasonable estimates, supported by interviews, project records, design documents, and the technical roles of employees, are often sufficient when properly developed and documented.

Taxpayers also regularly assume that being paid by a customer disqualifies them from claiming the credit. This misunderstanding is especially common in engineering, architecture, manufacturing, and contract development environments. The real issue is not whether a client paid for the work, but who bore the financial risk and who retained rights to the research. In many cases, contracts allocate risk in a way that still allows the service provider to claim the credit, even when the work is performed for a customer.

Fear of audit is another powerful deterrent. The R&D credit has a reputation—sometimes deserved—for scrutiny. That said, risk is not binary. A well-supported credit that clearly ties qualified activities to qualified research expenditures is very different from a loosely assembled claim. For many taxpayers, the risk of leaving substantial credits unclaimed year after year outweighs the risk of a properly documented filing position.

Finally, entity structure often becomes an unnecessary barrier. S corporations, partnerships, and pass-through entities frequently assume the credit is irrelevant or unusable. In reality, while the mechanics differ, these entities can and do benefit from R&D credits—either through income tax offsets, payroll tax offsets, or through owner-level utilization.

For CPAs, the practical lesson is this: initial objections should be treated as screening points, not automatic disqualifiers. When a client says, “We don’t qualify because…,” that statement is often the beginning of the analysis, not the end.

What Actually Drives the Credit: Qualified Research Expenditures (QREs)

Once the discussion moves past whether a taxpayer could qualify for the R&D credit, the next logical question is how the credit is actually calculated. While the statutory formula can appear complex, the building blocks are straightforward. The credit is driven by Qualified Research Expenditures (QREs)—the costs incurred while performing qualifying research activities.

In practice, QREs generally fall into three categories: wages, contractor costs, and supplies. Of these, wages are almost always the dominant component.

Qualified wages include amounts paid to employees who perform, directly supervise, or directly support qualified research activities. This extends beyond engineers and developers. Project managers, technical leads, and certain supervisory personnel may also generate QREs, provided their involvement is directly tied to the qualifying work. Identifying who meaningfully contributes to the technical problem-solving process is often more important than job titles.

Contractor costs are another potential source of QREs, but they require closer scrutiny. Only a portion of amounts paid to third parties may qualify, and eligibility depends heavily on the terms of the underlying contract. Specifically, the taxpayer must generally bear the financial risk of the research and retain substantial rights to the results. This makes contract review a critical step in any serious R&D analysis, particularly for firms that rely heavily on outsourced development, engineering, or testing.

Supplies tend to be the smallest and most misunderstood category. These are tangible items consumed in the research process—materials used in prototyping, testing, or trial runs. Capital equipment, depreciable assets, and general administrative supplies are excluded. While supplies rarely drive the bulk of a credit, they can still provide incremental value when properly identified.

For CPAs, the takeaway is that the R&D credit is not built on abstract notions of innovation—it is built on real payroll, real projects, and real expenses. Understanding where a client’s people spend their time, how contractors are engaged, and what materials are consumed during development efforts is the foundation of a defensible and meaningful credit calculation.

The Four-Part Test: How the IRS Defines “Qualified Research”

Every dollar included in a Research & Development credit calculation must ultimately tie back to the IRS’s definition of qualified research. That definition is embodied in what practitioners commonly refer to as the four-part test. While the test is statutory, it is best understood as a practical framework for evaluating whether day-to-day business activities rise to the level required for the credit.

The first prong asks whether the activity is intended to create a new or improved product, process, software, technique, formula, or invention. Importantly, “new or improved” is measured relative to the taxpayer—not the industry or the world at large. Enhancing performance, increasing reliability, improving scalability, or reducing cost can all satisfy this requirement.

The second prong focuses on uncertainty. At the outset of the project, the taxpayer must be uncertain about how to achieve the desired result. This uncertainty may relate to the appropriate design, methodology, materials, or technical capability. If the path forward is already known and routine, the activity will generally fall outside the scope of qualified research.

The third prong requires that the activity be technological in nature, relying on principles of physical science, biological science, engineering, or computer science. This requirement excludes purely aesthetic, stylistic, or business-driven changes, while capturing the vast majority of technical problem-solving work performed by engineers, developers, and skilled trades.

The final prong—the process of experimentation—is often the most misunderstood and the most critical. The taxpayer must evaluate one or more alternatives to resolve the identified uncertainty. This does not require formal lab experiments. Iterative design, modeling, simulation, prototyping, trial-and-error testing, and engineering judgment all qualify when they are used to compare and refine potential solutions.

Viewed together, the four-part test is not a checklist designed to exclude businesses—it is a framework designed to identify how technical work is actually performed. Many qualifying activities do not look like “research” in the academic sense. They look like engineers troubleshooting a system, developers iterating on code, or manufacturers refining a process that didn’t work the first time.

For CPAs, this test provides a practical lens for evaluating eligibility. If a client’s team is routinely working through technical uncertainty using engineering or scientific principles, there is a strong likelihood that at least a portion of that work meets the IRS definition of qualified research.

Documentation Reality Check: You Don’t Need Perfect Time Sheets to Start

One of the biggest reasons otherwise eligible taxpayers never pursue the R&D credit is a belief that their documentation is insufficient. In particular, many assume that without detailed, contemporaneous time tracking by project, a claim cannot be supported. In practice, this assumption stops more credits than the law ever intended.

While documentation is essential, the IRS does not require perfect records. The standard is one of reasonableness. Taxpayers must be able to demonstrate that qualified activities occurred and that the associated expenditures were incurred in connection with those activities. How that demonstration is made depends heavily on the nature of the business and the way it operates.

In many industries, especially engineering, architecture, manufacturing, and software development, employees do not track time in a way that neatly maps to tax definitions. Instead, support for the credit is often built through a combination of interviews with technical personnel, project documentation, design files, change orders, test results, internal communications, and an understanding of employee roles and responsibilities. When these elements are synthesized coherently, they can form a defensible basis for allocating time to qualified research.

It is also important to recognize that the rules have evolved. Earlier administrative guidance placed heavier emphasis on contemporaneous time tracking, but subsequent clarifications and case law have reinforced that reasonable estimates, when grounded in credible evidence, are acceptable. The absence of time sheets does not eliminate eligibility; it simply shifts the focus to alternative forms of substantiation.

For CPAs, the key is to reframe the conversation with clients. The question is not whether documentation is “perfect,” but whether it is sufficient and reconstructible. If a taxpayer can explain what technical problems were being solved, who was involved, and how the work progressed, the foundation for documentation likely already exists—even if it does not live in a formal time-tracking system.

Contractor Risk and Contract Language: Who Really “Owns” the R&D?

For taxpayers that rely on third-party contractors, outsourced development, or project-based technical services, one of the most critical R&D credit questions is not what work was performed, but who bore the financial risk of that work. This issue frequently determines whether contractor costs can be included as Qualified Research Expenditures—or excluded entirely.

The R&D credit rules do not automatically disqualify work performed by contractors. Instead, they focus on two key concepts: financial risk and substantial rights. In general, the taxpayer claiming the credit must bear the risk that the research may fail and must retain rights to use or exploit the results of the research.

This is where contract language becomes decisive. Fixed-fee or milestone-based contracts often suggest that the contractor bears little risk, particularly if payment is guaranteed regardless of outcome. Conversely, agreements that tie compensation to performance, deliverables, or successful outcomes may indicate that the taxpayer retains meaningful risk. Similarly, intellectual property clauses, licensing terms, and usage rights can either support or undermine a credit position.

In many cases, taxpayers assume that because a customer ultimately paid for the work, the credit is unavailable. That assumption is often incorrect. It is entirely possible for a service provider to qualify for the credit even when working for a client, provided the provider retains sufficient risk and rights under the agreement. Conversely, it is also possible for a taxpayer to be fully funded yet still fail the risk test due to unfavorable contract terms.

From a CPA’s perspective, this makes contract review a gating step, not an afterthought. Determining who owns the R&D is not a philosophical exercise—it is a legal and factual analysis grounded in the actual language of the agreements governing the work. In many situations, modest changes to contract structure or a clearer understanding of existing terms can significantly alter the credit outcome.

The broader takeaway is that contractor involvement does not disqualify an R&D credit, but it does require careful attention. Without reviewing contracts and understanding how risk and rights are allocated, it is impossible to accurately assess eligibility or quantify qualifying expenditures.

Back-of-the-Napkin Credit Sizing for Client Conversations

Before committing time and resources to a full R&D credit study, CPAs often need a quick way to answer a simple question: Is this worth pursuing at all? While a formal calculation requires detailed analysis, a high-level estimate can usually be developed in just a few minutes.

A practical starting point is payroll. Because wages typically make up the majority of Qualified Research Expenditures, the fastest way to screen an opportunity is to identify how much the client spends on employees engaged in technical or problem-solving work. This includes engineers, developers, designers, technical managers, and others who meaningfully contribute to qualifying activities.

From there, apply a reasonable qualifying percentage. This percentage represents the portion of those employees’ time that is likely devoted to activities that meet the four-part test. In many industries, this is far lower than clients expect—but still material. Even a modest qualifying percentage can produce meaningful results when applied to a large payroll base.

Once qualifying wages are estimated, a rough credit rate can be applied. While the actual calculation depends on methodology and historical data, a conservative rule of thumb often places the federal credit in the range of 5% to 10% of qualified wages. This is not a substitute for a detailed analysis, but it is usually sufficient to determine whether the potential benefit is five figures or seven figures.

For example, a company with $2 million in technical payroll and a 20% qualifying factor would have $400,000 of qualified wages. Applying a conservative 7% credit rate yields an estimated federal credit of $28,000 per year—before considering state credits, lookback opportunities, or payroll tax offsets. In larger organizations, these numbers scale quickly.

For CPAs, this approach serves two purposes. First, it helps prioritize where to spend advisory time. Second, it reframes the conversation from abstract eligibility to concrete dollars. When clients can see even a rough estimate of potential value, they are far better equipped to decide whether a deeper review makes sense.

Industries Where CPAs Routinely Miss R&D Eligibility

One of the reasons the R&D credit remains underutilized is that it is still mentally associated with a narrow set of industries—technology startups, pharmaceutical labs, and large manufacturers. In practice, however, some of the most consistently overlooked R&D opportunities arise in businesses that do not think of themselves as “research-driven” at all.

Architecture and engineering firms are a prime example. These firms routinely confront technical uncertainty, evaluate alternative designs, model performance, and refine solutions to meet site-specific constraints. From a tax perspective, much of this work aligns closely with the four-part test. Yet R&D eligibility is often dismissed early because the work is performed for clients or because innovation is seen as incremental rather than groundbreaking. In reality, it is not uncommon for 5% to 30% of technical payroll in these firms to be associated with qualifying activities, depending on project mix and delivery model.

Manufacturing is another frequently missed category, particularly among mid-sized and privately held companies. Process improvements, tooling redesigns, production-line optimization, and efforts to reduce defects or increase efficiency often involve systematic experimentation and engineering judgment. Because these activities are embedded in “normal operations,” they are rarely labeled as research, even though they may meet the statutory definition.

Software development extends well beyond pure technology companies. Custom internal-use software, system integrations, automation tools, and data-processing platforms developed by companies in logistics, finance, healthcare, and professional services can all qualify. The key is whether the development involved technical uncertainty and iterative problem-solving—not whether the end product is sold externally.

Food and beverage, construction, environmental services, and specialty contracting businesses also regularly perform qualifying activities. Recipe development, materials testing, equipment modification, and compliance-driven innovation can all involve experimentation and technical risk, even when the end result looks routine to the taxpayer.

For CPAs, the takeaway is not to memorize a list of qualifying industries, but to recognize a pattern. Wherever businesses are paying skilled employees to solve technical problems, adapt designs to real-world constraints, or improve how something functions, there is a strong possibility that R&D eligibility exists. Industry stereotypes often obscure this reality—and that is where opportunities are most often missed.

Startups and Loss Companies: Why Profitability Is Not Required

A persistent misconception about the R&D tax credit is that it only benefits profitable companies. As a result, many early-stage businesses, growth companies, and taxpayers operating at a loss assume the credit has little or no value to them. In reality, profitability is not a prerequisite for benefiting from the R&D credit.

While profitable companies can apply the credit directly against income tax liability, certain taxpayers—most notably startups and small to mid-sized businesses—may be eligible to use the credit to offset payroll taxes. This allows companies with limited or no income tax liability to convert qualifying research activity into near-term cash-flow relief, even during periods of investment or expansion.

From a planning perspective, this feature significantly broadens the relevance of the credit. Businesses reinvesting heavily in growth often have substantial payroll and technical expenditures long before they generate consistent taxable income. For those companies, the ability to offset payroll taxes can provide a meaningful financial bridge during critical development phases.

Even for loss companies that do not currently benefit from payroll offsets, R&D credits are not wasted. Credits that cannot be used immediately may be carried forward, preserving value for future profitable years. When combined with lookback opportunities, this means that qualifying activity today can translate into tax savings well beyond the current filing cycle.

For CPAs advising startups and growth-oriented clients, the key takeaway is to avoid dismissing the R&D credit based solely on current tax posture. The credit is designed to support innovation across the business lifecycle, not just at maturity. In many cases, identifying and documenting qualifying activities early can position clients to realize significant benefits when their financial profile changes.

Section 41 Didn’t Fundamentally Change — Section 174 Did (and It Created the “R&D Drama”)

One of the most important clarifications for CPAs to internalize is this: the R&D credit itself did not materially change. Section 41—the statute governing the R&D credit—largely remained intact. What changed, and what caused widespread disruption, was Section 174.

For decades, many taxpayers expensed research-related costs currently, often without giving Section 174 much explicit attention. That long-standing treatment created an implicit assumption across the profession that research costs and the R&D credit naturally worked together. When Section 174 capitalization became mandatory, that assumption collapsed.

Under the revised Section 174 rules, taxpayers were required to capitalize and amortize specified research or experimental expenditures, regardless of whether they claimed an R&D credit. Domestic research costs became subject to a five-year amortization period, while foreign research costs were amortized over fifteen years. This change applied broadly and mechanically, without regard to whether the taxpayer ever intended to pursue a credit under Section 41.

The result was immediate confusion. Many taxpayers—and advisors—began to conflate the two sections, assuming that Section 174 capitalization somehow replaced, limited, or disqualified the R&D credit. In reality, the two provisions serve different purposes. Section 41 provides a credit for qualified research activities. Section 174 governs the timing of deductions for research-related expenditures. They operate in parallel, not in opposition.

This distinction matters because Section 174 applies even when no credit is claimed. Taxpayers who never pursued the R&D credit still found themselves required to capitalize costs they had historically deducted. Conversely, claiming an R&D credit did not eliminate or reduce the capitalization requirement. The disconnect between expectation and reality is what fueled much of the frustration and uncertainty that followed.

For CPAs, this section of the analysis is foundational. Many client conversations stalled—or never started—because Section 174 changes were mistakenly viewed as “R&D credit changes.” Understanding that the credit itself remained largely stable, while the expense treatment shifted dramatically, is essential to resetting the planning discussion and identifying where opportunities still exist.

What Section 174 Capitalization Did in Practice (and Why It Hurt)

When Section 174 capitalization became mandatory, its impact was both immediate and, for many taxpayers, unexpectedly severe. The change did not merely alter timing at the margins—it fundamentally shifted how research-intensive businesses experienced taxable income.

Under the revised rules, research and experimental expenditures could no longer be fully deducted in the year incurred. Instead, domestic research costs were required to be amortized over five years, while foreign research costs were spread over fifteen years. Critically, this treatment applied regardless of whether the underlying research ultimately succeeded or failed. Taxpayers were forced to capitalize costs even when projects produced no viable product or revenue.

In practice, this created a significant timing mismatch. Companies continued to incur large payroll and development costs up front, but the associated deductions were delayed. For many businesses—particularly those operating on thin margins or reinvesting heavily in growth—this resulted in higher taxable income without a corresponding increase in cash flow. In some cases, companies that were economically unprofitable found themselves paying income tax.

The ripple effects extended beyond tax calculations. Some businesses reduced or delayed research activity altogether. Others attempted to reclassify or restructure development efforts to avoid capitalization. Still others absorbed the impact but found themselves constrained in hiring, capital investment, or expansion plans. The policy objective of encouraging innovation was, at least temporarily, undermined by the cash-flow strain imposed on the very taxpayers engaged in that innovation.

From a compliance standpoint, the change also introduced significant complexity. Many taxpayers had never explicitly tracked Section 174 costs, relying instead on historical expensing practices. Suddenly, they were required to identify, segregate, capitalize, and amortize research expenditures with a level of precision that was unfamiliar and burdensome.

For CPAs, the challenge was twofold. First, there was the technical burden of implementing a new and rigid capitalization regime. Second, there was the client-facing reality of explaining why tax liabilities had increased even though business fundamentals had not changed. Understanding this practical impact is essential to appreciating why Section 174 became such a flashpoint—and why subsequent legislative relief was so closely watched.

The “Wild West” Period: How Taxpayers and Practitioners Reacted

In the wake of mandatory Section 174 capitalization, the profession entered what can best be described as a “Wild West” period. With limited guidance, delayed legislative action, and mounting client pressure, taxpayers and practitioners adopted a wide range of approaches—some cautious, some aggressive, and many driven by necessity rather than clarity.

One common response was full compliance paired with continued R&D credit claims. These taxpayers accepted capitalization under Section 174 while still pursuing credits under Section 41, recognizing that the two provisions operated independently. While technically sound, this approach often produced unpleasant cash-flow results, particularly in the early years of amortization.

Other taxpayers attempted to avoid the issue altogether by assuming that if no R&D credit was claimed, Section 174 would not apply. In many cases, this assumption proved incorrect. Section 174 is not elective, and it does not hinge on whether a credit is pursued. As a result, some taxpayers found themselves exposed upon later review, having neither claimed the credit nor properly capitalized research costs.

A third group pulled back from innovation itself. Faced with higher tax bills and uncertainty, some businesses scaled down development efforts, delayed projects, or shifted resources away from activities that might trigger capitalization. While understandable from a short-term cash perspective, this reaction ran counter to the long-term intent of both the credit and the underlying policy.

Finally, many practitioners and taxpayers adopted a wait-and-see approach, anticipating legislative relief. Amendments, delays, and proposed fixes circulated widely, but definitive resolution took time. During this period, filings reflected a patchwork of interpretations, risk tolerances, and planning philosophies.

For CPAs, this era underscored a critical lesson: uncertainty in the law does not eliminate the need for decisions—it merely makes them harder. The diversity of approaches taken during this period is precisely why understanding the subsequent relief provisions, and how they interact with prior filings, is so important for current planning.

The OBBBA Relief Framework: Who Qualifies as a “Small Business Taxpayer”

The legislative response to the disruption caused by Section 174 capitalization ultimately arrived in the form of relief provisions under the One Big Beautiful Bill Act (OBBBA). While the relief is not universal, it is highly meaningful for a large segment of taxpayers, particularly privately held and closely held businesses.

At the center of the relief framework is the definition of a “small business taxpayer.” For purposes of the OBBBA provisions discussed in this session, a taxpayer generally qualifies if its average annual gross receipts do not exceed $31 million, calculated over the prior three taxable years. In practical terms, this means looking at gross receipts for 2022, 2023, and 2024, adding them together, and dividing by three.

This threshold captures far more taxpayers than many initially expect. A wide range of engineering firms, manufacturers, software developers, professional service firms, and closely held operating companies fall comfortably below the $31 million mark. For those taxpayers, the OBBBA opens the door to retroactive relief from mandatory Section 174 capitalization that had previously increased taxable income and strained cash flow.

Importantly, this relief is not automatic. Eligibility must be evaluated carefully, and taxpayers must take affirmative steps to implement the available remedies. However, the framework fundamentally changes the planning conversation. Instead of asking how to live with Section 174 capitalization, qualifying taxpayers can now ask how best to unwind or mitigate it.

For CPAs, this section of the analysis is critical. Identifying whether a client meets the gross receipts test is the gateway to all subsequent planning options. Once that threshold is met, the focus shifts from compliance damage control to strategic decision-making—choosing the method that best aligns with the client’s tax posture, cash-flow needs, and long-term plans.

If Eligible for Retroactive Treatment: The Three Main Paths Forward

Once a taxpayer qualifies as a small business taxpayer under the OBBBA relief framework, the next question is no longer whether relief is available, but how to implement it. The legislation and accompanying guidance provide several paths forward, each with different cash-flow, compliance, and planning implications.

The first option is to amend prior-year returns to remove Section 174 capitalization and restore the historical expensing treatment. This approach most closely aligns with how many taxpayers treated research costs before the rule change. For clients that paid tax as a direct result of capitalization, amended returns can generate refunds and provide near-term liquidity. However, amendments can also reopen prior-year filings and may require additional coordination depending on entity type.

The second option allows taxpayers to expense the cumulative capitalized Section 174 costs in the current year. Rather than reopening prior returns, the taxpayer effectively takes a “catch-up” deduction in the year of relief. This approach can be attractive for clients seeking simplicity or those for whom amendments are impractical. The timing benefit, however, depends heavily on current-year taxable income and net operating loss limitations.

The third option permits taxpayers to spread the catch-up deduction across two years, typically the current year and the following year. This election may be beneficial where a full deduction in a single year would generate losses that cannot be efficiently utilized, or where smoothing taxable income produces a better overall result.

Choosing among these paths is not a mechanical exercise. Each option interacts differently with net operating losses, credit utilization, state conformity, and future planning strategies. For CPAs, the key is to move beyond the availability of relief and into comparative analysis—evaluating which path produces the most favorable outcome given the client’s broader tax profile.

Editor’s Note: Clarifying the Five Technical Paths Under Section 174 Relief

While the OBBBA relief framework is often described as offering four paths forward for Section 174 research expenditures, it is more accurate from a practitioner’s perspective to view the rules as creating five distinct technical options.

This distinction arises because the statute and procedural guidance separate the treatment of previously capitalized research costs from the treatment of new research expenditures going forward. As a result, taxpayers may arrive at outcomes that are technically distinct, even if they are sometimes grouped together in higher-level summaries.

In practical terms, taxpayers now have five technical options:

Continue capitalizing and amortizing all Section 174 costs, both existing and future, without acceleration or retroactive relief.
Continue amortizing previously capitalized Section 174 costs while expensing new domestic research expenditures, as permitted under current law.
Accelerate the deduction of previously capitalized Section 174 costs, either in a single year or spread over two years, while expensing new costs going forward.
Retroactively expense previously capitalized Section 174 costs through amended returns, available to eligible small business taxpayers.
Elect to capitalize and amortize new domestic research expenditures, even though immediate expensing is now allowed.

While all five approaches are technically permissible, options one and five are generally not the most favorable for most taxpayers, as they defer deductions and delay cash-flow benefits. As a result, planning discussions typically focus on the remaining options, which better align deduction timing with economic reality and liquidity needs.

The key takeaway for CPAs is that Section 174 relief is not a one-size-fits-all solution. Proper planning requires understanding not only what is allowed, but which options are strategically optimal given the taxpayer’s income profile, entity structure, and long-term objectives.

Method Changes, Form 3115, and Section 481(a): How the Relief Is Actually Implemented

Once a taxpayer decides which Section 174 path to pursue, the next question is procedural: how is that decision implemented on the return? This is where much of the anxiety around Section 174 relief arises, particularly due to the frequent—and often unnecessary—invocation of accounting method change rules.

Not every Section 174 decision requires a formal change in accounting method. The key distinction is whether the taxpayer is changing an existing method, or simply applying a new statutory rule prospectively.

If a taxpayer continues amortizing previously capitalized Section 174 costs exactly as they were originally reported, no method change occurs. The taxpayer is merely continuing an existing accounting treatment. Likewise, when a taxpayer begins expensing new domestic research expenditures under current law, that treatment is generally considered a change in law, not a discretionary method change. In those situations, no Form 3115 and no Section 481(a) adjustment are required.

Form 3115 becomes relevant when the taxpayer takes an affirmative step to change an existing accounting method. This most commonly occurs when the taxpayer elects to accelerate the remaining unamortized balance of previously capitalized Section 174 costs. In that case, the change is implemented through an automatic accounting method change, with the cumulative difference reflected as a Section 481(a) adjustment in the year of change.

A Form 3115 may also be required if a taxpayer affirmatively elects to capitalize and amortize new domestic research expenditures, even though immediate expensing is now permitted. Because this election represents a voluntary method choice rather than a statutory default, it generally must be made consistently and documented through the method change process.

From a planning perspective, the presence or absence of a Section 481(a) adjustment is critical. Accelerating previously capitalized costs can generate large, front-loaded deductions, but those deductions must be evaluated in the context of net operating loss limitations, credit utilization, and future income expectations. In some cases, a slower deduction profile may actually produce a better long-term outcome.

For CPAs, the takeaway is that Form 3115 is a tool—not a default requirement. Understanding when a method change is truly required, and when it is not, prevents unnecessary compliance work and helps ensure that Section 174 relief is implemented efficiently and correctly.

Entity-Specific Considerations: Why Structure Drives the Section 174 Decision

Although the Section 174 relief framework applies broadly, entity structure plays a significant role in determining which option is most practical—or even feasible—for a given taxpayer. The same statutory choices can produce very different results depending on whether the business operates as a partnership, S corporation, or C corporation.

For partnerships, particularly those subject to the centralized partnership audit regime (the BBA rules), procedural considerations often dominate the analysis. Amending prior-year partnership returns can be administratively complex, time-consuming, and disruptive to partners—especially when ownership has changed or when multiple tiers are involved. As a result, many partnerships gravitate toward prospective solutions, such as accelerating previously capitalized costs through a Section 481(a) adjustment or allowing amortization to continue while expensing new costs. These approaches often provide meaningful relief without reopening closed years or requiring partner-level amended filings.

S corporations present a different set of tradeoffs. While amended returns are generally easier than in a partnership context, the impact of deductions and credits ultimately flows through to shareholders, who may or may not be able to efficiently use them. Accelerating deductions in a year when shareholders lack sufficient basis or are subject to loss limitations may blunt the benefit. In these cases, spreading deductions over time or aligning relief with anticipated income can produce a better result, even if it appears less aggressive on the surface.

For C corporations, the analysis often centers on taxable income, net operating losses, and credit utilization. Accelerating Section 174 deductions may generate or increase NOLs, but those losses are subject to utilization limits in future years. In some cases, expensing all costs immediately creates deductions that cannot be fully monetized in the near term, reducing the practical value of acceleration. C corporations may also be more sensitive to financial statement considerations, making smoother deduction profiles preferable.

Across all entity types, ownership changes, exit strategies, and transaction timelines matter. A taxpayer planning to sell the business, bring in investors, or restructure ownership may prioritize certainty and simplicity over maximum short-term deductions. Conversely, taxpayers under cash-flow pressure may prioritize immediate relief, even if it creates complexity.

For CPAs, the key takeaway is that Section 174 planning cannot be done in a vacuum. The optimal choice depends not only on what the law allows, but on how deductions, credits, and compliance obligations flow through the taxpayer’s specific entity structure. Understanding those dynamics is essential to selecting the right path forward.

Cost Segregation Refresher: Why Timing Is the Whole Game

Cost segregation is often described as a depreciation strategy, but that framing understates its real purpose. At its core, cost segregation is a timing strategy—one designed to accelerate deductions into earlier years without changing the total amount of depreciation a taxpayer is entitled to over the life of a property.

When a commercial or rental property is placed in service, it is typically depreciated as a single asset over 27.5 or 39 years. A cost segregation study dissects that property into its component parts, identifying elements that qualify for shorter recovery periods—most commonly 5-, 7-, or 15-year property. By reclassifying those components, depreciation deductions are shifted forward into earlier years.

That shift in timing is where the value lies. Earlier deductions reduce taxable income sooner, improve cash flow, and increase the present value of tax savings. When paired with bonus depreciation or other acceleration mechanisms, cost segregation can generate substantial first-year deductions without altering the taxpayer’s long-term depreciation profile.

What makes cost segregation particularly relevant in the current environment is how it interacts with broader planning considerations under the OBBBA. Changes to bonus depreciation, combined with Section 174 relief and net operating loss limitations, mean that when a deduction is taken can be just as important as whether it is taken. A deduction that arrives too early—or too late—may be less effective than one timed to coincide with taxable income.

For CPAs, cost segregation should not be viewed as an isolated “real estate play.” It is a tool that fits into a larger timing framework, interacting with entity structure, credit utilization, financing arrangements, and exit strategies. Understanding that context is essential before recommending a study or dismissing one.

A Simple Cost Segregation Example: Putting Numbers to the Concept

To understand how cost segregation works in practice, it helps to walk through a simplified example. While real studies involve detailed engineering analysis, the economic effect can be illustrated with relatively straightforward numbers.

Assume a taxpayer acquires a commercial building for $10 million and places it in service. For simplicity, assume that 20% of the purchase price is allocated to land, which is not depreciable. That leaves $8 million of depreciable basis.

Under traditional depreciation, that $8 million would generally be depreciated over 39 years, producing annual deductions of roughly $205,000 per year, with only a partial deduction in the first year due to mid-month conventions. From a cash-flow perspective, the tax benefit is spread thinly across decades.

Now introduce a cost segregation study. Through an engineering-based analysis, the study identifies portions of the building that qualify as shorter-lived property. A conservative allocation might look like this:

25% reclassified to 5-year property
10% reclassified to 15-year property
The remaining 65% continues to be depreciated over 39 years

Under this allocation, $2.8 million of the building’s basis is shifted into shorter recovery periods. If bonus depreciation is available, a significant portion of that $2.8 million may be deductible in the year the property is placed in service or shortly thereafter.

Even without full bonus depreciation, the acceleration effect is substantial. Instead of waiting decades to recover those costs, the taxpayer pulls a meaningful portion of the deductions into the first several years of ownership. That acceleration reduces taxable income early in the investment lifecycle—often when debt service is highest and cash flow is most constrained.

The total depreciation taken over time does not change. What changes is when those deductions are realized. When combined with current tax rates, net operating loss rules, and other planning considerations, the present value of those earlier deductions can far exceed the value of slower, straight-line depreciation.

For CPAs, this type of example is often sufficient to determine whether a deeper analysis is warranted. If the accelerated deductions align with the client’s income profile and long-term plans, cost segregation can be a powerful tool. If not, it may be more prudent to defer or forego the strategy altogether.

The OBBBA Depreciation Toolbox: Bonus Depreciation, Elections, and Timing

Cost segregation does not operate in isolation. Its effectiveness depends heavily on how it interacts with the broader depreciation rules in effect at the time a property is placed in service. Under the OBBBA, those rules have shifted in ways that materially affect planning outcomes.

The most visible lever is bonus depreciation. Bonus depreciation allows taxpayers to deduct a percentage of qualifying short-lived property in the year it is placed in service, rather than spreading those deductions over time. Under the OBBBA framework discussed in this session, bonus depreciation for qualifying property placed in service after the relevant effective date returns to 100%, while property placed in service earlier may be subject to a reduced percentage. This timing distinction alone can swing the economics of a cost segregation study by hundreds of thousands—or millions—of dollars.

Equally important are the elections available to taxpayers. Bonus depreciation is not mandatory. Taxpayers may elect out entirely or elect out by class of property. In some cases, taking 100% bonus depreciation produces deductions that exceed current taxable income, resulting in net operating losses that cannot be fully utilized due to statutory limitations. In those situations, electing out of bonus depreciation—or applying it selectively—may produce a better overall result by aligning deductions with income.

Section 179 expensing adds another layer of flexibility. While subject to its own limits and eligibility requirements, Section 179 can be used to target specific assets for immediate expensing while allowing other depreciation to flow through on a slower schedule. When coordinated properly, this can fine-tune deduction timing without the all-or-nothing effect of bonus depreciation.

The central theme is control. Cost segregation identifies what can be accelerated. Bonus depreciation, Section 179, and related elections determine how much acceleration actually occurs. Under the OBBBA, taxpayers have more ability than in recent years to shape the timing of deductions in a way that aligns with cash flow, credit utilization, and long-term tax planning objectives.

For CPAs, the takeaway is that recommending a cost segregation study is only the first step. The real value comes from integrating the study into a coordinated depreciation strategy—one that considers income projections, net operating loss limitations, and future transaction plans. Without that integration, even technically correct depreciation can be economically inefficient.

When Cost Segregation (or Bonus Depreciation) May Not Be the Right Answer

Despite its potential benefits, cost segregation is not universally advantageous. In some situations, accelerating depreciation can actually reduce the overall effectiveness of a taxpayer’s planning strategy. Recognizing these scenarios is just as important as identifying opportunities.

One common caution area is short holding periods. If a taxpayer expects to sell a property within a relatively short timeframe—often two to three years—the benefits of accelerated depreciation may be offset by depreciation recapture upon disposition. While recapture does not eliminate the benefit entirely, it can significantly reduce the net advantage, particularly when combined with transaction costs and capital gain considerations.

Another consideration is net operating loss utilization. Accelerating deductions into years where taxable income is already low—or nonexistent—may create losses that cannot be fully utilized due to statutory limitations. In those cases, a slower depreciation profile may actually yield more usable deductions over time, even if the total depreciation is unchanged.

Exit strategy matters as well. Taxpayers planning a sale, merger, or Section 1031 exchange may prioritize simplicity, predictability, or basis preservation over front-loaded deductions. In certain transaction contexts, introducing aggressive depreciation can complicate negotiations, due diligence, or post-transaction tax modeling.

Financing arrangements can also influence the analysis. Some lenders view aggressive depreciation skeptically, particularly when it materially affects reported income or covenant calculations. While tax depreciation and book depreciation differ, the optics and downstream effects should not be ignored.

Finally, there are situations where electing out of bonus depreciation—either partially or entirely—produces a better outcome. The ability to control timing under the OBBBA means taxpayers are no longer forced into all-or-nothing decisions. Strategic restraint can be just as valuable as acceleration.

For CPAs, the key takeaway is that cost segregation should be evaluated as part of a holistic tax strategy, not as a default recommendation. The most effective planning occurs when acceleration is used deliberately, in alignment with the taxpayer’s income profile, financing structure, and long-term objectives.

The 179D Tie-In: Energy Efficiency as a Parallel Planning Opportunity

While cost segregation focuses on accelerating depreciation, Section 179D operates on a different axis: it provides a deduction tied to energy efficiency, not asset recovery periods. When viewed together, the two provisions can significantly enhance the overall tax outcome of real estate projects, particularly for commercial properties.

Section 179D allows a deduction for qualifying energy-efficient improvements to commercial buildings, including lighting systems, HVAC and hot water systems, and building envelope components. Unlike depreciation-based incentives, the 179D deduction is not spread over time. When properly claimed, it can produce a substantial one-time deduction tied to the level of efficiency achieved.

One of the most important aspects of Section 179D is that ownership is not always required to benefit. In the case of government-owned buildings—such as schools, municipal facilities, and other public-sector projects—the deduction can often be allocated to the designer of the property. This creates a powerful planning opportunity for architecture, engineering, and design-build firms that may not otherwise associate themselves with real estate tax incentives.

From a coordination standpoint, 179D and cost segregation frequently apply to the same projects but operate independently. A cost segregation study accelerates depreciation on qualifying components, while 179D rewards the taxpayer (or designer) for achieving energy performance thresholds. When layered together, the combined deductions can materially improve project economics without overlapping or double-counting benefits.

Timing is also critical. Section 179D is typically tied to the year a building is placed in service or the year qualifying improvements are completed. As a result, it should be evaluated early in the planning process—ideally before depreciation elections are finalized—so that both incentives can be optimized together.

For CPAs, the takeaway is that energy efficiency incentives should not be siloed. When a client is considering cost segregation, or when a firm is involved in designing or improving commercial buildings, Section 179D should be part of the same strategic conversation. Properly coordinated, these tools can unlock deductions that would otherwise remain hidden, even for taxpayers who believe they have already “optimized” their depreciation.

A Practitioner’s Checklist: Spotting Opportunities in 15 Minutes

The themes discussed throughout this article—R&D credits, Section 174 relief, cost segregation, and energy incentives—can feel complex in isolation. In practice, however, many opportunities can be identified quickly by asking the right screening questions. The goal is not to perform a full analysis in a first conversation, but to determine whether a deeper review is warranted.

Below is a practical checklist CPAs can use to triage potential opportunities in as little as 15 minutes.

R&D Credit Screening

Does the client employ engineers, developers, designers, or other technical personnel?
Are employees regularly solving technical problems, refining processes, or working through uncertainty?
Is technical work performed for internal use, custom solutions, or client-specific projects?
Does the client lack formal time tracking but have project records, design files, or technical documentation?
Are contractors involved, and do contracts suggest the client bears financial risk or retains rights?

Section 174 Exposure and Relief

Did the client capitalize research costs in 2022–2024 due to Section 174?
Is average gross receipts under approximately $31 million for the applicable lookback period?
Did capitalization materially increase taxable income or create cash-flow strain?
What entity type is involved (partnership, S corporation, C corporation)?
Would accelerated deductions be usable, or would they create unusable losses?

Cost Segregation Triggers

Has the client acquired, constructed, or substantially renovated commercial or rental property?
Was the property placed in service within the last several years?
Are there significant components related to electrical, plumbing, finishes, or site work?
Does the client expect to hold the property long enough to benefit from acceleration?
Are bonus depreciation elections aligned with income projections?

179D Energy Efficiency Indicators

Is the client involved in commercial construction, renovation, or design?
Were energy-efficient lighting, HVAC, or envelope systems installed?
Is the project associated with a government-owned building?
Was the firm involved as a designer rather than an owner?

If several of these questions trigger “yes” responses, the likelihood of missed tax benefits is high. At that point, the CPA’s role shifts from screening to coordination—bringing in the appropriate technical expertise to validate, document, and implement the strategy correctly.

Closing Thoughts: Coordination, Not Complexity

The common thread running through R&D credits, Section 174 relief, cost segregation, and energy efficiency incentives is not complexity—it is coordination. Each of these tools already exists in the Code. What has changed is how they interact, how timing affects their value, and how easily opportunities can be missed when they are evaluated in isolation.

Recent legislative changes have not eliminated uncertainty, but they have shifted the planning landscape. Assumptions that were reasonable just a few years ago may no longer hold. Mandatory capitalization under Section 174 altered cash-flow dynamics. Subsequent relief reopened doors that many taxpayers assumed were closed. Depreciation rules under the OBBBA reintroduced flexibility that makes timing decisions more consequential than ever.

For CPAs, this environment reinforces an important point: effective tax planning is no longer about identifying a single strategy and applying it broadly. It is about asking the right questions early, understanding how multiple provisions intersect, and recognizing when specialized analysis is warranted. In many cases, the greatest value comes not from aggressive positions, but from thoughtful alignment—matching deductions and credits to the client’s income profile, entity structure, and long-term objectives.

Ultimately, these strategies are not about chasing incentives for their own sake. They are about helping clients deploy capital more efficiently, reinvest in their businesses, and avoid leaving material benefits unclaimed due to outdated assumptions or fragmented analysis. When approached deliberately and coordinated properly, the tools discussed in this article can materially improve outcomes without increasing risk.

That balance—between opportunity and prudence—is where strong advisory work lives.

Navigating R&D Credits, Section 174 Relief, and Cost Segregation After the OBBBA

Complex Tax Credit & Incentive Matters: What Your Business Needs to Know